Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Airsculpt Technologies Inc (AIRS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/13/2025: AIRS (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $4.5
1 Year Target Price $4.5
| 0 | Strong Buy |
| 0 | Buy |
| 4 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 40.06% | Avg. Invested days 25 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 06/13/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 305.83M USD | Price to earnings Ratio - | 1Y Target Price 4.5 |
Price to earnings Ratio - | 1Y Target Price 4.5 | ||
Volume (30-day avg) 4 | Beta 2.51 | 52 Weeks Range 1.53 - 9.20 | Updated Date 06/29/2025 |
52 Weeks Range 1.53 - 9.20 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.29 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -9.95% | Operating Margin (TTM) -4.04% |
Management Effectiveness
Return on Assets (TTM) -4.44% | Return on Equity (TTM) -21.3% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 402075726 | Price to Sales(TTM) 1.78 |
Enterprise Value 402075726 | Price to Sales(TTM) 1.78 | ||
Enterprise Value to Revenue 2.34 | Enterprise Value to EBITDA 18.63 | Shares Outstanding 62413800 | Shares Floating 10662665 |
Shares Outstanding 62413800 | Shares Floating 10662665 | ||
Percent Insiders 26.73 | Percent Institutions 69.28 |
Analyst Ratings
Rating 2 | Target Price 4.5 | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold 4 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Airsculpt Technologies Inc
Company Overview
History and Background
Airsculpt Technologies Inc. (ticker: AIRS) was founded to offer minimally invasive body contouring procedures. They developed and commercialized the AirSculpt procedure. The company has grown through expanding its locations and service offerings.
Core Business Areas
- AirSculpt Procedures: AirSculpt Technologies specializes in delivering its patented AirSculpt body contouring procedure, a minimally invasive alternative to traditional liposuction.
- Center Operations: The company operates and manages a network of body contouring centers across the United States and Canada.
Leadership and Structure
The leadership team is composed of executives with experience in medical aesthetics and business management. The organizational structure includes roles for operations, marketing, and finance, structured to manage the clinic network and brand.
Top Products and Market Share
Key Offerings
- AirSculpt Procedure: AirSculpt is the company's core offering, providing fat removal and body sculpting with minimal downtime. Market share data is not publicly available. Competitors include traditional liposuction procedures and other minimally invasive body contouring technologies. Competitors include Cutera (CUTR), InMode (INMD) and Cynosure (CYNO).
Market Dynamics
Industry Overview
The medical aesthetics industry is experiencing growth driven by increased consumer demand for non-invasive and minimally invasive cosmetic procedures. The market is competitive, with technological advancements driving innovation.
Positioning
AirSculpt Technologies positions itself as a leader in minimally invasive body contouring, emphasizing its patented technology and focus on patient experience.
Total Addressable Market (TAM)
The TAM for body contouring is estimated to be in the billions of dollars globally. AirSculpt is positioned to capture a portion of this market through its unique procedure and growing clinic network.
Upturn SWOT Analysis
Strengths
- Patented AirSculpt technology
- Minimally invasive procedure
- Strong brand recognition
- Expanding clinic network
Weaknesses
- High procedure cost
- Limited geographic presence relative to competitors
- Reliance on a single procedure type
Opportunities
- Expansion into new geographic markets
- Development of new AirSculpt applications
- Partnerships with complementary service providers
- Increased marketing and brand awareness campaigns
Threats
- Competition from established players in cosmetic surgery
- Technological advancements leading to alternative procedures
- Economic downturn impacting consumer spending on elective procedures
- Regulatory changes affecting the medical aesthetics industry
Competitors and Market Share
Key Competitors
- Cutera (CUTR)
- InMode (INMD)
- Cynosure (CYNO)
Competitive Landscape
AirSculpt's strength lies in its patented technology and brand. Weaknesses include higher procedure costs and a more limited geographic footprint compared to established competitors offering a broader range of aesthetic treatments.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends are reflected in their revenue growth as they expand locations and procedures.
Future Projections: Future growth is projected to come from expanding the clinic network and increasing market penetration.
Recent Initiatives: Recent initiatives include opening new clinics and implementing marketing campaigns to increase brand awareness.
Summary
AirSculpt Technologies is a growing company leveraging patented technology in the medical aesthetics market. Its expansion strategy is reliant on expanding its network of clinics. Key challenges will be navigating competition and managing costs. Continued innovation is needed to ensure competitiveness in the long run.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- Industry reports
- Public Filings
Disclaimers:
This analysis is based on publicly available information and does not constitute financial advice. Market share data is estimated.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Airsculpt Technologies Inc
Exchange NASDAQ | Headquaters Miami Beach, FL, United States | ||
IPO Launch date 2021-10-29 | CEO & Director Mr. Yogesh Jashnani | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 389 | Website https://airsculpt.com |
Full time employees 389 | Website https://airsculpt.com | ||
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company's body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.